Neuromodulation for neurodegenerative conditions

Frontiers in Bioscience - Elite

Volumn 5 E, Issue 2, 2013, Pages 490-499

  Tierney, Travis S ^a   Vasudeva, Viren S ^a   Weir, Sharada ^b   Hayes, Michael T ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Deep brain stimulation; Huntington's disease; Parkinson's disease; Review; Secondary dystonia

Indexed keywords

4 AMINOBUTYRIC ACID; BACLOFEN; GLUTAMATE DECARBOXYLASE; LEVODOPA;

ADENOVIRUS; ALZHEIMER DISEASE; ARTICLE; BRADYKINESIA; BRAIN DEPTH STIMULATION; BRAIN THIRD VENTRICLE; CHOREA; CLINICAL TRIAL (TOPIC); COGNITION; COGNITIVE DEFECT; COST EFFECTIVENESS ANALYSIS; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DYSKINESIA; DYSTONIA; FOLLOW UP; GLOBUS PALLIDUS; HUMAN; HUNTINGTON CHOREA; MEMORY; MEYNERT BASAL NUCLEUS; MOTOR DYSFUNCTION; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROMODULATION; OPTOGENETICS; PARIETAL LOBE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PATIENT CARE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIMARY PREVENTION; PYRAMIDAL TRACT; SUBTHALAMIC NUCLEUS; UNSPECIFIED SIDE EFFECT; METHODOLOGY; REVIEW;

CHOREA; COGNITION DISORDERS; DEEP BRAIN STIMULATION; DYSTONIA; HUMANS; NEURODEGENERATIVE DISEASES; OPTOGENETICS;

MLCS; MLOWN;

EID: 84878521076     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e630     Document Type: Article

References (112)

1. W. Birkmayer and O. Hornykiewicz: [The L-3, 4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia]. Wien Klin Wochenschr 73, 787-788 (1961)
2. G. C. Cotzias, P. S. Papavasiliou and R. Gellene: Modification of Parkinsonism-chronic treatment with Ldopa. N Engl J Med 280(7), 337-345 (1969)
3. C. D. Marsden and J. D. Parkes: "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet 1(7954), 292-296 (1976)
4. O. Lindvall and Z. Kokaia: Stem cells in human neurodegenerative disorders-time for clinical translation? J Clin Invest 120(1), 29-40 (2010)
5. J. S. Lunn, S. A. Sakowski, J. Hur and E. L. Feldman: Stem cell technology for neurodegenerative diseases. Ann Neurol 70(3), 353-361 (2011)
6. K. Urbaniak Hunter, C. Yarbrough and J. Ciacci: Geneand cell-based approaches for neurodegenerative disease. Adv Exp Med Biol 671, 117-130 (2010)
7. J. Guridi, J. A. Obeso, M. C. Rodriguez-Oroz, A. A. Lozano and M. Manrique: L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease. Neurosurgery 62(2), 311-23; discussion 323-325 (2008)
8. E. Moro, A. M. Lozano, P. Pollak, Y. Agid, S. Rehncrona, J. Volkmann, J. Kulisevsky, J. A. Obeso, A. Albanese, M. I. Hariz, N. P. Quinn, J. D. Speelman, A. L. Benabid, V. Fraix, A. Mendes, M. L. Welter, J. L. Houeto, P. Cornu, D. Dormont, A. L. Tornqvist, R. Ekberg, A. Schnitzler, L. Timmermann, L. Wojtecki, A. Gironell, M. C. Rodriguez-Oroz, J. Guridi, A. R. Bentivoglio, M. F. Contarino, L. Romito, M. Scerrati, M. Janssens and A. E. Lang: Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 25(5), 578-586 (2010)
9. T. Sankar and A. M. Lozano: Surgical approach to ldopainduced dyskinesias. Int Rev Neurobiol 98, 151-171 (2011)
10. G. Deuschl, C. Schade-Brittinger, P. Krack, J. Volkmann, H. Schafer, K. Botzel, C. Daniels, A. Deutschlander, U. Dillmann, W. Eisner, D. Gruber, W. Hamel, J. Herzog, R. Hilker, S. Klebe, M. Kloss, J. Koy, M. Krause, A. Kupsch, D. Lorenz, S. Lorenzl, H. M. Mehdorn, J. R. Moringlane, W. Oertel, M. O. Pinsker, H. Reichmann, A. Reuss, G. H. Schneider, A. Schnitzler, U. Steude, V. Sturm, L. Timmermann, V. Tronnier, T. Trottenberg, L. Wojtecki, E. Wolf, W. Poewe and J. Voges: A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 355(9), 896-908 (2006)
11. F. M. Weaver, K. Follett, M. Stern, K. Hur, C. Harris, W. J. Marks, Jr., J. Rothlind, O. Sagher, D. Reda, C. S. Moy, R. Pahwa, K. Burchiel, P. Hogarth, E. C. Lai, J. E. Duda, K. Holloway, A. Samii, S. Horn, J. Bronstein, G. Stoner, J. Heemskerk and G. D. Huang: Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301(1), 63-73 (2009)
12. A. Williams, S. Gill, T. Varma, C. Jenkinson, N. Quinn, R. Mitchell, R. Scott, N. Ives, C. Rick, J. Daniels, S. Patel and K. Wheatley: Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, openlabel trial. Lancet Neurol 9(6), 581-591 (2010)
13. J. Dams, B. Bornschein, J. P. Reese, A. Conrads-Frank, W. H. Oertel, U. Siebert and R. Dodel: Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review. Pharmacoeconomics 29(12), 1025-1049 (2011)
14. V. Fraix, J. L. Houeto, C. Lagrange, C. Le Pen, P. Krystkowiak, D. Guehl, C. Ardouin, M. L. Welter, F. Maurel, L. Defebvre, A. Rougier, A. L. Benabid, V. Mesnage, M. Ligier, S. Blond, P. Burbaud, B. Bioulac, A. Destee, P. Cornu, P. Pollak and S. S. Group: Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 77(4), 443-449 (2006)
15. F. Valldeoriola, O. Morsi, E. Tolosa, J. Rumia, M. J. Marti and P. Martinez-Martin: Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease. Mov Disord 22(15), 2183-2191 (2007)
16. T. S. Tierney and A. M. Lozano: Intervention options: functional neurosurgery. In: Rehabilitation in Movement Disorders. Eds: R. Iansek and M. E. Morris. Cambridge University Press, Cambridge (In press)
17. P. D. Charles, R. M. Dolhun, C. E. Gill, T. L. Davis, M. J. Bliton, M. G. Tramontana, R. M. Salomon, L. Wang, P. Hedera, F. T. Phibbs, J. S. Neimat and P. E. Konrad: Deep brain stimulation in early Parkinson's disease: enrollment experience from a pilot trial. Parkinsonism Relat Disord 18(3), 268-273 (2012)
18. A. Schnitzler, G. Fuchs, H. Baas, U. Dillmann, R. Hilker and M. Oechsner: [Early deep brain stimulation for Parkinson's disease]. Fortschr Neurol Psychiatr 78 Suppl 1, S37-S40 (2010)
19. C. C. McIntyre, M. Savasta, L. Kerkerian-Le Goff and J. L. Vitek: Uncovering the mechanism (s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol 115(6), 1239-1248 (2004)
20. J. S. Perlmutter and J. W. Mink: Deep brain stimulation. Annu Rev Neurosci 29, 229-57 (2006)
21. V. C. Anderson, K. J. Burchiel, P. Hogarth, J. Favre and J. P. Hammerstad: Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 62(4), 554-560 (2005)
22. A. Castrioto, A. M. Lozano, Y. Y. Poon, A. E. Lang, M. Fallis and E. Moro: Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 68(12), 1550-1556 (2011)
23. P. Krack, A. Batir, N. Van Blercom, S. Chabardes, V. Fraix, C. Ardouin, A. Koudsie, P. D. Limousin, A. Benazzouz, J. F. LeBas, A. L. Benabid and P. Pollak: Five year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 349(20), 1925-1934 (2003)
24. J. Volkmann, N. Allert, J. Voges, V. Sturm, A. Schnitzler and H. J. Freund: Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol 55(6), 871-875 (2004)
25. K. Dujardin, L. Defebvre, P. Krystkowiak, S. Blond and A. Destee: Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease. J Neurol 248(7), 603-611 (2001)
26. M. S. Okun, J. Green, R. Saben, R. Gross, K. D. Foote and J. L. Vitek: Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. J Neurol Neurosurg Psychiatry 74(11), 1584-1586 (2003)
27. H. M. Smeding, J. D. Speelman, M. Koning-Haanstra, P. R. Schuurman, P. Nijssen, T. van Laar and B. Schmand: Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology 66(12), 1830-1836 (2006)
28. J. M. Hausdorff, L. Gruendlinger, L. Scollins, S. O'Herron and D. Tarsy: Deep brain stimulation effects on gait variability in Parkinson's disease. Mov Disord 24(11), 1688-1692 (2009)
29. E. L. Johnsen, P. H. Mogensen, N. A. Sunde and K. Ostergaard: Improved asymmetry of gait in Parkinson's disease with DBS: gait and postural instability in Parkinson's disease treated with bilateral deep brain stimulation in the subthalamic nucleus. Mov Disord 24(4), 590-597 (2009)
30. L. Castelli, L. Rizzi, M. Zibetti, S. Angrisano, M. Lanotte and L. Lopiano: Neuropsychological changes 1-year after subthalamic DBS in PD patients: A prospective controlled study. Parkinsonism Relat Disord 16(2), 115-118 (2010)
31. M. S. Okun, H. H. Fernandez, S. S. Wu, L. Kirsch-Darrow, D. Bowers, F. Bova, M. Suelter, C. E. t. Jacobson, X. Wang, C. W. Gordon, Jr., P. Zeilman, J. Romrell, P. Martin, H. Ward, R. L. Rodriguez and K. D. Foote: Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 65(5), 586-595 (2009)
32. M. K. York, M. Dulay, A. Macias, H. S. Levin, R. Grossman, R. Simpson and J. Jankovic: Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 79(7), 789-795 (2008)
33. R. Zangaglia, C. Pacchetti, C. Pasotti, F. Mancini, D. Servello, E. Sinforiani, S. Cristina, M. Sassi and G. Nappi: Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study. Mov Disord 24(11), 1621-1628 (2009)
34. K. Witt, C. Daniels, J. Reiff, P. Krack, J. Volkmann, M. O. Pinsker, M. Krause, V. Tronnier, M. Kloss, A. Schnitzler, L. Wojtecki, K. Botzel, A. Danek, R. Hilker, V. Sturm, A. Kupsch, E. Karner and G. Deuschl: Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 7(7), 605-614 (2008)
35. V. Voon, P. Krack, A. E. Lang, A. M. Lozano, K. Dujardin, M. Schupbach, J. D'Ambrosia, S. Thobois, F. Tamma, J. Herzog, J. D. Speelman, J. Samanta, C. Kubu, H. Rossignol, Y. Y. Poon, J. A. Saint-Cyr, C. Ardouin and E. Moro: A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131(Pt 10), 2720-2728 (2008)
36. T. S. Tierney, T. Sankar and A. M. Lozano: Some recent trends and further promising directions in functional neurosurgery. Acta Neurol Scand, In press (2012)
37. D. Aarsland, L. Marsh and A. Schrag: Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 24(15), 2175-2186 (2009)
38. S. E. Soh, M. E. Morris and J. L. McGinley: Determinants of health-related quality of life in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 17(1), 1-9 (2011)
39. A. Merola, M. Zibetti, S. Angrisano, L. Rizzi, V. Ricchi, C. A. Artusi, M. Lanotte, M. G. Rizzone and L. Lopiano: Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. Brain 134(Pt 7), 2074-2084 (2011)
40. M. A. Hely, W. G. Reid, M. A. Adena, G. M. Halliday and J. G. Morris: The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 23(6), 837-844 (2008)
41. M. E. Morris, R. Iansek and B. Galna: Gait festination and freezing in Parkinson's disease: pathogenesis and rehabilitation. Mov Disord 23 Suppl 2, S451-S460 (2008)
42. G. N. Orlovsky, F. V. Severin and M. L. Shik: Locomotion elicited by midbrain stimulation (trans. Russian). Proc Acad Sci USSR 169, 1223-1226 (1966)
43. P. A. Pahapill and A. M. Lozano: The pedunculopontine nucleus and Parkinson's disease. Brain 123(Pt 9), 1767-1783 (2000)
44. M. U. Ferraye, B. Debu, V. Fraix, L. Goetz, C. Ardouin, J. Yelnik, C. Henry-Lagrange, E. Seigneuret, B. Piallat, P. Krack, J. F. Le Bas, A. L. Benabid, S. Chabardes and P. Pollak: Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 133(Pt 1), 205-214 (2010)
45. P. Mazzone, S. Sposato, A. Insola, V. Dilazzaro and E. Scarnati: Stereotactic surgery of nucleus tegmenti pedunculopontine [corrected]. Br J Neurosurg 22 Suppl 1, S33-S40 (2008)
46. E. A. Pereira, K. A. Muthusamy, N. De Pennington, C. A. Joint and T. Z. Aziz: Deep brain stimulation of the pedunculopontine nucleus in Parkinson's disease. Preliminary experience at Oxford. Br J Neurosurg 22 Suppl 1, S41-S44 (2008)
47. A. Stefani, A. M. Lozano, A. Peppe, P. Stanzione, S. Galati, D. Tropepi, M. Pierantozzi, L. Brusa, E. Scarnati and P. Mazzone: Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 130(Pt 6), 1596-1607 (2007)
48. E. Moro, C. Hamani, Y. Y. Poon, T. Al-Khairallah, J. O. Dostrovsky, W. D. Hutchison and A. M. Lozano: Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 133(Pt 1), 215-224 (2010)
49. W. Thevathasan, T. J. Coyne, J. A. Hyam, G. Kerr, N. Jenkinson, T. Z. Aziz and P. A. Silburn: Pedunculopontine nucleus stimulation improves gait freezing in Parkinson disease. Neurosurgery 69(6), 1248-1253; discussion 1254 (2011)
50. S. Khan, L. Mooney, P. Plaha, S. Javed, P. White, A. L. Whone and S. S. Gill: Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease. Br J Neurosurg 25(2), 273-280 (2011)
51. P. Mazzone, A. Insola, S. Sposato and E. Scarnati: The deep brain stimulation of the pedunculopontine tegmental nucleus. Neuromodulation 12(3), 191-204 (2009)
52. A. J. Stoessl: Gene therapy for Parkinson's disease: early data. Lancet 369(9579), 2056-2058 (2007)
53. C. Svendsen: The first steps towards gene therapy for Parkinson's disease. Lancet Neurol 6(9), 754-756 (2007)
54. M. G. Kaplitt, A. Feigin, C. Tang, H. L. Fitzsimons, P. Mattis, P. A. Lawlor, R. J. Bland, D. Young, K. Strybing, D. Eidelberg and M. J. During: Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369(9579), 2097-2105 (2007)
55. P. A. LeWitt, A. R. Rezai, M. A. Leehey, S. G. Ojemann, A. W. Flaherty, E. N. Eskandar, S. K. Kostyk, K. Thomas, A. Sarkar, M. S. Siddiqui, S. B. Tatter, J. M. Schwalb, K. L. Poston, J. M. Henderson, R. M. Kurlan, I. H. Richard, L. Van Meter, C. V. Sapan, M. J. During, M. G. Kaplitt and A. Feigin: AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 10(4), 309-319 (2011)
56. C. W. Christine, P. A. Starr, P. S. Larson, J. L. Eberling, W. J. Jagust, R. A. Hawkins, H. F. Van Brocklin, J. F. Wright, K. S. Bankiewicz and M. J. Aminoff: Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology 73(20), 1662-1669 (2009)
57. W. J. Marks, Jr., R. T. Bartus, J. Siffert, C. S. Davis, A. Lozano, N. Boulis, J. Vitek, M. Stacy, D. Turner, L. Verhagen, R. Bakay, R. Watts, B. Guthrie, J. Jankovic, R. Simpson, M. Tagliati, R. Alterman, M. Stern, G. Baltuch, P. A. Starr, P. S. Larson, J. L. Ostrem, J. Nutt, K. Kieburtz, J. H. Kordower and C. W. Olanow: Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol 9(12), 1164-1172 (2010)
58. W. J. Marks, Jr., J. L. Ostrem, L. Verhagen, P. A. Starr, P. S. Larson, R. A. Bakay, R. Taylor, D. A. Cahn-Weiner, A. J. Stoessl, C. W. Olanow and R. T. Bartus: Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an openlabel, phase I trial. Lancet Neurol 7(5), 400-408 (2008)
59. S. W. Hung, C. Hamani, A. M. Lozano, Y. Y. Poon, P. Piboolnurak, J. M. Miyasaki, A. E. Lang, J. O. Dostrovsky, W. D. Hutchison and E. Moro: Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology 68(6), 457-459 (2007)
60. A. Kupsch, R. Benecke, J. Muller, T. Trottenberg, G. H. Schneider, W. Poewe, W. Eisner, A. Wolters, J. U. Muller, G. Deuschl, M. O. Pinsker, I. M. Skogseid, G. K. Roeste, J. Vollmer-Haase, A. Brentrup, M. Krause, V. Tronnier, A. Schnitzler, J. Voges, G. Nikkhah, J. Vesper, M. Naumann and J. Volkmann: Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 355(19), 1978-1990 (2006)
61. J. Mueller, I. M. Skogseid, R. Benecke, A. Kupsch, T. Trottenberg, W. Poewe, G. H. Schneider, W. Eisner, A. Wolters, J. U. Muller, G. Deuschl, M. O. Pinsker, G. K. Roeste, J. Vollmer-Haase, A. Brentrup, M. Krause, V. Tronnier, A. Schnitzler, J. Voges, G. Nikkhah, J. Vesper, M. Naumann and J. Volkmann: Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord 23(1), 131-134 (2008)
62. M. Vidailhet, L. Vercueil, J. L. Houeto, P. Krystkowiak, A. L. Benabid, P. Cornu, C. Lagrange, S. Tezenas du Montcel, D. Dormont, S. Grand, S. Blond, O. Detante, B. Pillon, C. Ardouin, Y. Agid, A. Destee and P. Pollak: Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 352(5), 459-467 (2005)
63. M. Vidailhet, L. Vercueil, J. L. Houeto, P. Krystkowiak, C. Lagrange, J. Yelnik, E. Bardinet, A. L. Benabid, S. Navarro, D. Dormont, S. Grand, S. Blond, C. Ardouin, B. Pillon, K. Dujardin, V. Hahn-Barma, Y. Agid, A. Destee and P. Pollak: Bilateral, pallidal, deep brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol 6(3), 223-229 (2007)
64. J. C. Wohrle, C. Blahak, H. H. Capelle, W. Fogel, H. Bazner and J. K. Krauss: Combined pallidal and subthalamic nucleus stimulation in sporadic dystoniaparkinsonism. J Neurosurg 116(1), 95-98 (2012)
65. A. L. Spieles-Engemann, K. Steece-Collier, M. M. Behbehani, T. J. Collier, S. L. Wohlgenant, C. J. Kemp, A. Cole-Strauss, N. D. Levine, S. E. Gombash, V. B. Thompson, J. W. Lipton and C. E. Sortwell: Subthalamic Nucleus Stimulation Increases Brain Derived Neurotrophic Factor in the Nigrostriatal System and Primary Motor Cortex. J Parkinsons Dis 1(1), 123-136 (2011)
66. T. S. Tierney, W. H. Ng, A. V. Sharma, H. Chau, S. Stone, C. Hamani and A. M. Lozano: High-frequency stimulation of the Papez circuit increases brain-derived neurotrophic factor (BDNF) expression and neurogenesis in the rat dentate gyrus. In: Society for Neuroscience. Washington, DC (2011)
67. T. D. Taylor, M. Litt, P. Kramer, M. Pandolfo, L. Angelini, N. Nardocci, S. Davis, M. Pineda, H. Hattori, P. J. Flett, M. R. Cilio, E. Bertini and S. J. Hayflick: Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet 14(4), 479-481 (1996)
68. B. Zhou, S. K. Westaway, B. Levinson, M. A. Johnson, J. Gitschier and S. J. Hayflick: A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28(4), 345-349 (2001)
69. M. Krause, W. Fogel, V. Tronnier, S. Pohle, K. Hortnagel, U. Thyen and J. Volkmann: Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Mov Disord 21(12), 2255-2257 (2006)
70. P. A. Starr, R. S. Turner, G. Rau, N. Lindsey, S. Heath, M. Volz, J. L. Ostrem and W. J. Marks, Jr.: Microelectrode-guided implantation of deep brain stimulators into the globus pallidus internus for dystonia: techniques, electrode locations, and outcomes. J Neurosurg 104(4), 488-501 (2006)
71. A. Umemura, J. L. Jaggi, C. A. Dolinskas, M. B. Stern and G. H. Baltuch: Pallidal deep brain stimulation for longstanding severe generalized dystonia in Hallervorden-Spatz syndrome. Case report. J Neurosurg 100(4), 706-709 (2004)
72. P. Castelnau, L. Cif, E. M. Valente, N. Vayssiere, S. Hemm, A. Gannau, A. Digiorgio and P. Coubes: Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 57(5), 738-741 (2005)
73. F. Clement, D. Devos, C. Moreau, P. Coubes, A. Destee and L. Defebvre: Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options. Acta Neurol Belg 107(1), 26-31 (2007)
74. T. S. Tierney and A. M. Lozano: Surgical treatment for secondary dystonia. Mov Disord In press
75. L. Timmermann, K. A. Pauls, K. Wieland, R. Jech, G. Kurlemann, N. Sharma, S. S. Gill, C. A. Haenggeli, S. J. Hayflick, P. Hogarth, K. L. Leenders, P. Limousin, C. J. Malanga, E. Moro, J. L. Ostrem, F. J. Revilla, P. Santens, A. Schnitzler, S. Tisch, F. Valldeoriola, J. Vesper, J. Volkmann, D. Woitalla and S. Peker: Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain 133(Pt 3), 701-712 (2010)
76. R. K. Narayan, P. G. Loubser, J. Jankovic, W. H. Donovan and C. F. Bontke: Intrathecal baclofen for intractable axial dystonia. Neurology 41(7), 1141-1142 (1991)
77. R. D. Penn and J. S. Kroin: Continuous intrathecal baclofen for severe spasticity. Lancet 2(8447), 125-127 (1985)
78. K. Woon, M. Tsegaye and M. H. Vloeberghs: The role of intrathecal baclofen in the management of primary and secondary dystonia in children. Br J Neurosurg 21(4), 355-358 (2007)
79. R. H. Walker, F. O. Danisi, D. M. Swope, R. R. Goodman, I. M. Germano and M. F. Brin: Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord 15(6), 1242-1247 (2000)
80. B. Ford, P. E. Greene, E. D. Louis, S. B. Bressman, R. R. Goodman, M. F. Brin, S. Sadiq and S. Fahn: Intrathecal baclofen in the treatment of dystonia. Adv Neurol 78, 199-210 (1998)
81. A. L. Albright, M. J. Barry, D. H. Shafton and S. S. Ferson: Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 43(10), 652-657 (2001)
82. A. L. Albright and S. S. Ferson: Intrathecal baclofen therapy in children. Neurosurg Focus 21(2), e3 (2006)
83. S. C. Burn, R. Zeller and J. M. Drake: Do baclofen pumps influence the development of scoliosis in children? J Neurosurg Pediatr 5(2), 195-199 (2010)
84. G. M. Ginsburg and A. J. Lauder: Progression of scoliosis in patients with spastic quadriplegia after the insertion of an intrathecal baclofen pump. Spine 32(24), 2745-2750 (2007)
85. J. M. Sansone, D. Mann, K. Noonan, D. McLeish, M. Ward and B. J. Iskandar: Rapid progression of scoliosis following insertion of intrathecal baclofen pump. J Pediatr Orthop 26(1), 125-128 (2006)
86. J. S. Shilt, L. P. Lai, M. N. Cabrera, J. Frino and B. P. Smith: The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. J Pediatr Orthop 28(6), 684-687 (2008)
87. F. Motta, C. E. Antonello and C. Stignani: Upper limbs function after intrathecal baclofen therapy in children with secondary dystonia. J Pediatr Orthop 29(7), 817-821 (2009)
88. A. L. Albright and S. S. Ferson: Intraventricular baclofen for dystonia: techniques and outcomes. Clinical article. J Neurosurg Pediatr 3(1), 11-14 (2009)
89. B. G. Rocque and A. L. Albright: Intraventricular versus intrathecal baclofen for secondary dystonia: a comparison of complications. Neurosurgery (2011, epub ahead of print)
90. Y. Fujimoto, E. Isozaki, F. Yokochi, K. Yamakawa, H. Takahashi and S. Hirai: [A case of chorea-acanthocytosis successfully treated with posteroventral pallidotomy]. Rinsho Shinkeigaku 37(10), 891-894 (1997)
91. J. L. Vitek, R. Jones, R. Bakay and S. Hersch: Pallidotomy for Huntington's disease. Ann Neurol 48, 429 (2000)
92. G. A. Kang, S. Heath, J. Rothlind and P. A. Starr: Long-term follow-up of pallidal deep brain stimulation in two cases of Huntington's disease. J Neurol Neurosurg Psychiatry 82(3), 272-277 (2011)
93. E. Moro, A. E. Lang, A. P. Strafella, Y. Y. Poon, P. M. Arango, A. Dagher, W. D. Hutchison and A. M. Lozano: Bilateral globus pallidus stimulation for Huntington's disease. Ann Neurol 56(2), 290-294 (2004)
94. A. Fasano, P. Mazzone, C. Piano, D. Quaranta, F. Soleti and A. R. Bentivoglio: GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case. Mov Disord 23(9), 1289-1292 (2008)
95. B. Biolsi, L. Cif, H. E. Fertit, S. G. Robles and P. Coubes: Long-term follow-up of Huntington disease treated by bilateral deep brain stimulation of the internal globus pallidus. J Neurosurg 109(1), 130-132 (2008)
96. M. O. Hebb, R. Garcia, P. Gaudet and I. M. Mendez: Bilateral stimulation of the globus pallidus internus to treat choreathetosis in Huntington's disease: technical case report. Neurosurgery 58(2), E383; discussion E383 (2006)
97. R. Brookmeyer, E. Johnson, K. Ziegler-Graham and H. M. Arrighi: Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3(3), 186-191 (2007)
98. I. M. Turnbull, P. L. McGeer, L. Beattie, D. Calne and B. Pate: Stimulation of the basal nucleus of Meynert in senile dementia of Alzheimer's type. A preliminary report. Appl Neurophysiol 48(1-6), 216-221 (1985)
99. H. J. Freund, J. Kuhn, D. Lenartz, J. K. Mai, T. Schnell, J. Klosterkoetter and V. Sturm: Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol 66(6), 781-785 (2009)
100. C. Hamani, M. P. McAndrews, M. Cohn, M. Oh, D. Zumsteg, C. M. Shapiro, R. A. Wennberg and A. M. Lozano: Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol 63(1), 119-123 (2008)
101. T. Sankar, T. S. Tierney and C. Hamani: Noval applications of deep brain stimulation. Surg Neurol Int 3, S26-S33 (2012)
102. T. P. S. Powell, R. W. Guillery and W. M. Cowan: A quantitative study of the fornix-mammillothalamic system.. J Anat 91, 419-432 (1957)
103. S. D. Vann, D. Tsivilis, C. E. Denby, J. R. Quamme, A. P. Yonelinas, J. P. Aggleton, D. Montaldi and A. R. Mayes: Impaired recollection but spared familiarity in patients with extended hippocampal system damage revealed by 3 convergent methods. Proc Natl Acad Sci U S A 106(13), 5442-5447 (2009)
104. A. W. Laxton, D. F. Tang-Wai, M. P. McAndrews, D. Zumsteg, R. Wennberg, R. Keren, J. Wherrett, G. Naglie, C. Hamani, G. S. Smith and A. M. Lozano: A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol 68(4), 521-534 (2010)
105. E. S. Boyden, F. Zhang, E. Bamberg, G. Nagel and K. Deisseroth: Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 8(9), 1263-1268 (2005)
106. G. Nagel, D. Ollig, M. Fuhrmann, S. Kateriya, A. M. Musti, E. Bamberg and P. Hegemann: Channelrhodopsin-1: a light-gated proton channel in green algae. Science 296(5577), 2395-2398 (2002)
107. F. Zhang, V. Gradinaru, A. R. Adamantidis, R. Durand, R. D. Airan, L. de Lecea and K. Deisseroth: Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures. Nat Protoc 5(3), 439-456 (2010)
108. F. Zhang, L. P. Wang, M. Brauner, J. F. Liewald, K. Kay, N. Watzke, P. G. Wood, E. Bamberg, G. Nagel, A. Gottschalk and K. Deisseroth: Multimodal fast optical interrogation of neural circuitry. Nature 446(7136), 633-639 (2007)
109. X. Han and E. S. Boyden: Multiple-color optical activation, silencing, and desynchronization of neural activity, with single-spike temporal resolution. PLoS One 2(3), e299 (2007)
110. V. Gradinaru, M. Mogri, K. R. Thompson, J. M. Henderson and K. Deisseroth: Optical deconstruction of parkinsonian neural circuitry. Science 324(5925), 354-359 (2009)
111. S. S. Stone, C. M. Teixeira, L. M. Devito, K. Zaslavsky, S. A. Josselyn, A. M. Lozano and P. W. Frankland: Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory. J Neurosci 31(38), 13469-13484 (2011)
112. H. Toda, C. Hamani, A. P. Fawcett, W. D. Hutchison and A. M. Lozano: The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation. J Neurosurg 108(1), 132-138 (2008)